Graf Akcie CNCE (Concert Pharmaceuticals Inc). Diskuze k akciím CNCE. Aktuální informace CNCE.

Základní informace o společnosti Concert Pharmaceuticals Inc (Akcie CNCE)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 94.59M
Hodnota podniku (EV) N/A
Tržby 33.53M
EBITDA N/A
Zisk -58.54
Růst v tržbách Q/Q 401.28 %
Růst v tržbách Y/Y 422.52 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.04
EV/Sales 0.30
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 2.82
P/FCF N/A
Price/Book 0.72
Účetní hodnota na akcii 4.09
Hotovost na akcii 4.15
FCF vůči ceně -49.45 %
Počet zaměstnanců 71
Tržba na zaměstnance 472.254k
Profit margin -946.17 %
Operating margin -174.84 %
Gross margin 100.00 %
EBIT margin -174.60 %
EBITDA margin -975.28 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -139.02 %
EPS - Očekávaný růst příští rok 35.00 %
Return on assets -38.94 %
Return on equity -47.22 %
ROIC -50.45 %
ROCE -41.81 %
Dluhy/Equity 0.21
Čistý dluh/EBITDA 6.36
Current ratio 15.34
Quick Ratio 15.34
Volatilita 4.86
Beta 0.66
RSI 38.68
Cílová cena analytiků 24
Známka akcie (dle analytiků) 1.00
Insider ownership 9.72 %
Institutional ownership 66.30 %
Počet akcií 32.174M
Procento shortovaných akcií 5.20 %
Short ratio 5.96 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie CNCE

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1.077$10.505$143.891$0.174$66.729$8.576
Cost Of Goods Sold------
Gross Profit$1.077$10.505$143.891$0.174$66.729$8.576
Research And Development Expenses$59.816$43.149$30.223$36.983$28.885$27.474
SG&A Expenses$20.276$22.94$21.019$14.358$13.056$11.7
Other Operating Income Or Expenses------
Operating Expenses$80.092$66.089$51.242$51.341$41.941$39.174
Operating Income$-79.015$-55.584$92.649$-51.167$24.788$-30.598
Total Non-Operating Income/Expense$0.849$-0.127$2.69$0.447$-0.185$-1.101
Pre-Tax Income$-78.166$-55.711$95.339$-50.72$24.603$-31.699
Income Taxes-$0.313$-0.3-$0.429-
Income After Taxes$-78.166$-56.024$95.639$-50.72$24.174$-31.699
Other Income------
Income From Continuous Operations$-78.166$-56.024$95.639$-50.72$24.174$-31.699
Income From Discontinued Operations------
Net Income$-78.166$-56.024$95.195$-50.72$24.174$-31.754
EBITDA$-78.364$-55.509$93.589$-50.085$26.083$-28.944
EBIT$-79.015$-55.584$92.649$-51.167$24.788$-30.598
Basic Shares Outstanding242323222116
Shares Outstanding242323222216
Basic EPS$-3.29$-2.40$4.20$-2.28$1.14$-2.00
EPS - Earnings Per Share$-3.29$-2.40$4.06$-2.28$1.09$-2.00
# 2020 2019 2018 2017 2016 2015
Current Ratio6.767120.590831.921517.545621.74564.3893
Long-term Debt / Capital------
Debt/Equity Ratio-----0.1295
Gross Margin100100100100100100
Operating Margin-7336.583-529.119464.3883-29406.3337.1473-356.7864
EBIT Margin-7336.583-529.119464.3883-29406.3337.1473-356.7864
EBITDA Margin-7276.137-528.405565.0416-28784.4839.0879-337.5
Pre-Tax Profit Margin-7257.753-530.328466.2578-29149.4336.87-369.6245
Net Profit Margin-7257.753-533.307966.1577-29149.4336.2271-370.2658
Asset Turnover0.00780.05460.67960.00170.45410.1015
Inventory Turnover Ratio------
Receiveable Turnover3.24418.3976183.76880.911265.85266.6843
Days Sales In Receivables112.516219.83961.9862400.66091.372954.6053
ROE - Return On Equity-77.0435-33.399348.6881-59.256518.505-57.8185
Return On Tangible Equity-77.0435-33.399348.6881-59.256518.505-57.8185
ROA - Return On Assets-56.86-29.096345.169-50.520516.4525-37.534
ROI - Return On Investment-77.0435-33.399348.6881-59.256518.505-57.8185
Book Value Per Share4.25137.15688.48893.83545.89383.0067
Operating Cash Flow Per Share0.0012-6.49536.4795-3.07512.9143-11.9545
Free Cash Flow Per Share0.0951-6.57766.4738-3.07082.926-11.7242

Porovnání s konkurencí: Akcie CNCE

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
CNCE 0.00 N/A 422.52 % 35.00 % -47.22 % 0.72 -946.17 %
Akcie ABBV 30.30 1.28 48.31 % 14.49 % 48.79 % 14.98 10.08 %
Akcie ABBV 30.30 1.28 48.31 % 14.49 % 48.79 % 14.98 10.08 %
Akcie ARDX 0.00 N/A 49.39 % 70.00 % -99.11 % 0.92 -1,245.71 %
Akcie ARDX 0.00 N/A 49.39 % 70.00 % -99.11 % 0.92 -1,245.71 %
Akcie GWPH 0.00 N/A 42.35 % 4.17 % -9.54 % 9.19 -11.03 %
Akcie GWPH 0.00 N/A 42.35 % 4.17 % -9.54 % 9.19 -11.03 %
Akcie JAZZ 122.50 4.98 18.46 % -24.36 % 1.07 % 2.15 10.10 %
Akcie JAZZ 122.50 4.98 18.46 % -24.36 % 1.07 % 2.15 10.10 %
Akcie TRVN 0.00 N/A N/A % 125.00 % -40.89 % 1.85 -956.96 %
Akcie TRVN 0.00 N/A N/A % 125.00 % -40.89 % 1.85 -956.96 %

Nedávné obchody insiderů: Akcie CNCE

Jméno Obchod Cena Objem
Thomas G Auchincloss
Director
Nákup
12 Mar 2020
$8.52 $12,780
Roger D Tung
Chief Executive Officer
Option
13 Mar 2020
$3.79 $55,338
Nancy Stuart
Chief Operating Officer
Option
22 Jun 2020
$3.79 $80,492
Marc A. Becker
Chief Financial Officer
Prodej
17 Aug 2020
$10.24 $29,440
James V Cassella
Chief Development Officer
Prodej
17 Aug 2020
$10.37 $45,151
Peter Barton Hutt
Director
Option
31 Aug 2020
$3.79 $13,413
Marc A. Becker
Chief Financial Officer
Prodej
16 Feb 2021
$7.32 $27,545
James V Cassella
Chief Development Officer
Prodej
16 Feb 2021
$7.32 $27,545
Jeffrey A Munsie
Chief Legal Officer
Prodej
16 Feb 2021
$7.32 $27,545
Nancy Stuart
Chief Operating Officer
Prodej
16 Feb 2021
$7.32 $44,279
Roger D Tung
Chief Executive Officer
Prodej
17 Feb 2021
$7.20 $97,056

Diskuze k akciím CNCE